In This Article:
- By insider
CFO of Repligen Corp (30-Year Financial, Insider Trades) Jon Snodgres (insider trades) sold 3,791 shares of RGEN on 11/10/2020 at an average price of $193.31 a share. The total sale was $732,838.
Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen Corp has a market cap of $9.83 billion; its shares were traded at around $186.90 with a P/E ratio of 227.93 and P/S ratio of 30.42. Repligen Corp had annual average EBITDA growth of 19.90% over the past five years. GuruFocus has detected 2 severe warning signs with Repligen Corp. .
CFO Recent Trades:
-
CFO Jon Snodgres sold 3,791 shares of RGEN stock on 11/10/2020 at the average price of $193.31. The price of the stock has decreased by 3.32% since.
Directors and Officers Recent Trades:
-
Director Nicolas Barthelemy sold 1,214 shares of RGEN stock on 11/09/2020 at the average price of $195.51. The price of the stock has decreased by 4.4% since.
For the complete insider trading history of RGEN, click here
.This article first appeared on GuruFocus.